Filter
156
Filtered Results: 156
Text search:
EMA
European
Medicines
Agency
Featured
Recommendations
18
New Publications
34
Language
Document type
No document type
56
Guidelines
43
Studies & Reports
25
Fact sheets
21
Manuals
6
Situation Updates
2
Strategic & Response Plan
2
Training Material
1
Countries / Regions
Germany
7
Western and Central Europe
5
Colombia
3
Africa
3
West and Central Africa
3
East and Southern Africa
2
Eastern Europe
2
Brazil
2
Tajikistan
1
Nepal
1
Thailand
1
Kenya
1
Ukraine
1
Sierra Leone
1
Chile
1
Peru
1
Philippines
1
Guinea
1
Cambodia
1
Venezuela
1
Latin America and the Carribbean
1
Congo, Democratic Republic of
1
Paraguay
1
Denmark
1
Spain
1
Argentina
1
Bangladesh
1
Uganda
1
Russia
1
Ethiopia
1
Zambia
1
Indonesia
1
Liberia
1
Ecuador
1
India
1
Authors & Publishers
Publication Years
Category
COVID-19
19
Guidelines
16
Hepatitis
10
Reproductive Health
5
Pediatrics
4
Drugs & Medical Equipment
4
HIV & STI
4
Pharmacy & Technologies
4
TB
4
MPOX - Monkeypox
3
Malaria
3
Hemorrhagic Fever
2
Medical Devices & Equipment
2
Information, Education and Communication (IEC)
2
Communicable Diseases
1
Paediatrics
1
Family Planning
1
Pharmacy & Technology
1
Buruli Ulcer
1
Diabetes
1
x MEDBOX Issue Brief & Annual Reports x
1
Cancer Treatment & Resources
1
Virology
1
Policies & Guidelines HIV & TB
1
Policies
1
Studies & Reports
1
Capacity Building
1
Humanitarian Crisis
1
Immunization
1
General Guidelines
1
Communicable Diseases
1
Neurology & Psychology
1
Human African Trypanosomiasis
1
Neonatal Care
1
Toolboxes
Country specific documents
13
Clinical Guidelines
12
Studies
7
Clinical Aspects, Treatment & Prevention
5
Drug resistant TB
5
Antiretroviral Treatment ART
5
Treatment & Prevention
4
Research
4
Communication Material
4
Immunization Guidelines
4
Vaxzevria (Astra Zeneca)
4
Assessment
4
Agriculture & Veterinary
3
International
3
Health Personnel
3
General
3
For Health Worker
3
MPOX - Monkeypox
3
General Public
3
Preparedness & Prevention
3
Drugs
2
Children & Adolescents
2
Substance Use Disorders, Others
2
Hepatitis
2
General Studies & Reports
2
Treatment Guidelines
2
Vaccine Hesitancy & Myths
2
Research & Pipeline
2
Essential Medicines
2
Supply Chain & Store Management
2
Rational use of Medicine
2
Pharmacovigilance
2
Mental Disorders
2
Antimicrobial Resistance (AMR)
2
MPOX -Monkeybox Prevention & Control
2
Clinical Aspects & Diagnostics
2
Substance Use Disorders & Addiction
2
Research & Access
2
Clinical Guidelines
2
Eastern Europe & Central Asia
2
Reports & Studies
2
Cocaine
1
Assessment & Studies
1
Surveillance
1
Childhood TB
1
Children with Disabilities
1
Ebola Prevention & Control
1
Europe
1
Prevention & Control
1
Vaccination
1
Adults
1
Opportunistic Infections
1
Policies & Programmes
1
Opoids
1
Diverse Chemical Substances
1
Global
1
Ebola
1
Children
1
Microcephaly
1
Context & Facts
1
Cannabis
1
Research & Development
1
Best Practice
1
For General Public & Community
1
Training, others
1
Clinical Guidelines
1
Scientific & Research Studies
1
Paediatrics
1
Oxygen Therapy
1
Essential Medicines & Medical Devices
1
Vaccination & Strategy
1
Access & Strategy
1
COVID-19 Vaccination
1
Logistics & Supply
1
Fair Allocation & Ethical Aspects
1
COVID-19 Vaccination Information
1
COVAX Initiative
1
Long COVID/ Post-COVID Syndrome
1
mRna Vaccines general
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Johnson & Johnson
1
Prices and Patents
1
Model Formulary
1
Pharmacy Management
1
Pharmacy Practice
1
Epilepsy
1
General Guidelines for Rational Use
1
Waste Managment
1
Reports & Studies
1
Capacity Building
1
Situation Reports & Updates
1
Guidelines & Manuals
1
Infectious Diseases
1
Water Pollution
1
MPOX - Monkeypox
1
Studies & Reports
1
Scabies
1
Global Overview
1
Alzheimer's Disease & Dementia
1
Human Rights & the Right to Health
1
Education of students & professionals
1
Roadmaps, Action Plans & Policies
1
Clinical Guidelines
1
Zika Prevention & Control
1
Tajikistan
1
Preparedness & Prevention
1
Depression
1
AMR
1
Eastern Europe and central Asia
1
This document has been developed as a guide to allinstitutions producing health care waste in planning and implementation of interventions that will reduce mismanagement of hazardous waste in Zambia.The National Health-Care Waste Management Plan for 2015 to 2019 provides an overv...
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, prsents current World Health Organization (WHO) guidance on the safety of various contraceptive e-
m...
The document is intended to facilitate the detection, evaluation and management of incident EVD cases in Germany. It primarily addresses public health service staff and health care workers in hospitals, outpatient clinics and emergency services in Germany. It is a work in progress, intended to evolv...
Lancet Planet Health 2017 Published Online November 6, 2017 http://dx.doi.org/10.1016/S2542-5196(17)30141-9
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
interim guidance, 19 July 2021 (arabic version)
29 September 2021
Consensual recommendations for outpatient management and home care
and home treatment of patients with COVID-19
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are ...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure t...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
